financetom
Business
financetom
/
Business
/
Golden Sun Gets Nasdaq Delisting Notification
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Golden Sun Gets Nasdaq Delisting Notification
Mar 25, 2024 2:35 PM

05:19 PM EDT, 03/25/2024 (MT Newswires) -- Golden Sun Health Technology ( GSUN ) , formerly Golden Sun Education, said late Monday it has received a letter from Nasdaq notifying its shares will be delisted unless it requested an appeal.

The stock exchange's decision is due to the company's failure to regain compliance with minimum bid price rule, the company said. Unless it requests an appeal of the decision by March 28, its shares will be suspended at the opening of business on April 2.

The company said it plans to appeal the decision. It's considering all options , including a reverse stock split.

Price: 0.53, Change: -0.01, Percent Change: -1.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Philips, Aspen Dental Launch Partnership Focusing on Sonicare Products
Philips, Aspen Dental Launch Partnership Focusing on Sonicare Products
Nov 3, 2024
11:18 AM EDT, 10/30/2024 (MT Newswires) -- Royal Philips (PHG) said Wednesday it is launching a partnership with Aspen Dental to bring its Sonicare toothbrush and related products to Aspen Dental's national network of more than 1,100 locations. Under the partnership, Aspen Dental's clinicians will be able offer Sonicare solutions in office, Philips said. Financial details weren't provided. Price: 26.14,...
Lexeo Therapeutics Sees 'Positive' Interim Results for LX1001 to Treat APOE4-Linked Alzheimer's Disease
Lexeo Therapeutics Sees 'Positive' Interim Results for LX1001 to Treat APOE4-Linked Alzheimer's Disease
Nov 3, 2024
11:04 AM EDT, 10/30/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Wednesday it has seen positive interim data from a phase 1/2 trial of LX1001 to treat APOE4-associated Alzheimer's disease. Treatment with the gene therapy candidate resulted in dose-dependent increases in APOE2 protein expression and improvements in AD-associated tau biomarkers, measures which have been closely correlated with cognitive...
Tharimmune Shares Climb on Positive Feedback From EMA on Potential Pruritus Therapy
Tharimmune Shares Climb on Positive Feedback From EMA on Potential Pruritus Therapy
Nov 3, 2024
11:06 AM EDT, 10/30/2024 (MT Newswires) -- Tharimmune ( THAR ) shares climbed by more than 130% in recent Wednesday trading after the company said it received positive feedback from the European Medicines Agency about TH104, its candidate to treat moderate-to-severe pruritus in primary biliary cholangitis, or PBC. The feedback came in a Scientific Advice meeting, the company said, where...
Shake Shack Stock Gains After Q3 Earnings Beat Amid Strong Sales Growth, Strategic Expansion
Shake Shack Stock Gains After Q3 Earnings Beat Amid Strong Sales Growth, Strategic Expansion
Nov 3, 2024
Shake Shack, Inc. ( SHAK ) shares are trading higher after the company reported better-than-expected third-quarter financial results. Shake Shack ( SHAK ) reported adjusted earnings per share of 25 cents, beating the street view of 20 cents. Quarterly revenues of $316.9 million (+14.7%) marginally outpaced the analyst consensus estimate of $316.13 million. Sales included $304.9 million from Shack sales...
Copyright 2023-2026 - www.financetom.com All Rights Reserved